We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
EPICENTRE Biotechnologies Introduces ScriptGuard™ RNase Inhibitor
Product News

EPICENTRE Biotechnologies Introduces ScriptGuard™ RNase Inhibitor

EPICENTRE Biotechnologies Introduces ScriptGuard™ RNase Inhibitor
Product News

EPICENTRE Biotechnologies Introduces ScriptGuard™ RNase Inhibitor


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "EPICENTRE Biotechnologies Introduces ScriptGuard™ RNase Inhibitor"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

EPICENTRE Biotechnologies has announced the avalibility of ScriptGuard™ RNase Inhibitor, a defense against common RNases including RNase A, RNase B, and RNase C’s. Its potent affinity for common RNases (Ki>10-14 M) can ensures protection of RNA samples even when trace amounts of RNase are present.

Advanced purification protocols and quality control tests ensure the recombinant ScriptGuard RNase Inhibitor is free of unwanted contaminants that can plague other commercially available preparations of RNase inhibitors.

ScriptGuard RNase Inhibitor does not interfere with enzymes commonly used to prepare or analyze RNA and is more resistant to inactivation by oxidation than other RNase inhibitors.

Advertisement